Terran Biosciences
PrivateLast Round
Series B
Feb 1, 2024
Company Overview
Terran Biosciences operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Series B round in February 2024.
Terran Biosciences is a biotechnology company that develops a platform for therapeutics and technologies for patients with neurological and psychiatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Mental Health, Medical Imaging, Medical AI
Business Model
B2B
Customer Profile
Usage-Based SaaS, Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Terran Biosciences Comparables
Compare Terran Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eli Lilly and Company | 77% | |
| Definium Therapeutics | 77% | |
| Gilgamesh Pharmaceuticals | 76% |
For institutional investors. Book with your work email.
Terran Biosciences Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Terran Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Magnetic Ventures | Series B |
| Catalytic Impact Foundation | Series B |
| Noetic Fund | Series B |
| Astir Ventures | Series B |
| Transhuman Capital | Series B |
| Magna Filis | Series B |
| The Brkfst Club | Series B |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors grew 119% MoM, reaching 1.7K.
- May 17, 2026
Monthly visitors grew 33% MoM.
For institutional investors. Book with your work email.
Terran Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Terran Biosciences's valuation, stock price, and market status.
Is Terran Biosciences a public or private company?
Terran Biosciences is a private company.
What is the current stock price of Terran Biosciences?
Terran Biosciences is a private company, so its shares have no public market price. Caplight tracks Terran Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Terran Biosciences worth (valuation)?
Valuation information for Terran Biosciences is not publicly available.
Can I buy Terran Biosciences stock?
Terran Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Terran Biosciences's last funding round?
Terran Biosciences's most recent funding round was Series B on February 1, 2024.
Who are the main investors in Terran Biosciences?
Key investors in Terran Biosciences include Magnetic Ventures, Catalytic Impact Foundation, Noetic Fund, Astir Ventures, Transhuman Capital.
Will Terran Biosciences IPO soon?
No public IPO plans have been announced for Terran Biosciences.
How can I track Terran Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Terran Biosciences's shares on secondary markets.